PATENT CLAIM ANALYSIS

Application Number: 16009093
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "210210"]

Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting plasma kallikrein. Furthermore, the subject compounds and compositions are useful for the treatment of diseases wherein the inhibition of plasma kallikrein inhibition has been implicated, such as angioedema and the like.

Claim (Index 81):
The compound of  claim 59 , or a pharmaceutically acceptable salt thereof, wherein Ring A is an optionally substituted quinolin-6-yl.

Metadata:
- Claim Count in Document: 126.0
- Percentile: 94.0
- Lexical Diversity: 1.52941
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15042102', '14800631', '15470736', '15807331', '11478547']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8168022351597176
- 35 USC 102 Novelty (BERT): 0.5782945983111185
- Combined Prediction Score: 0.7929514714748578
- Mean Citation Score: 416.284212
- Max Citation Score: 485.7676
- Similarity Product: 401.5647201171875

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test